Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DNA/RNA Synthesis
    (3)
  • KLF
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

ml264

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | Activity
ML264
CID-51003603
T68941550008-55-3
ML264 (CID-51003603) is a selective kruppel-like factor 5 (KLF5) inhibitor, which potently Inhibits growth of Colorectal Cancer.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
BML264
(E)-ACA,(E)-N-(p-Amylcinnamoyl) anthranilic acid
T8895399196-74-4
BML264 ((E)-N-(p-amylcinnamoyl) anthranilic acid) acts as an agonist for TREK-1. This compound is utilized in researching diseases related to TASK1 dysfunction.
  • Inquiry Price
10-14 weeks
Size
QTY
SR18662 free base
T93072505001-62-5
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide a.k.a. SR18662 is a KLF5 inhibitor optimized on the basis of the structure of ML264. It inhibits the growth of colorectal cancer in vitro and in vivo.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
SR18662
T22429
SR18662, an optimized compund based on ML264 that inhibits Krüppel-like factor 5 (KLF5) with IC50 of 4.4 nM, reduces the viability of multiple colorectal cancer cell lines and induces apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
YD277
YD 277,YD-277
T29172
YD277 is a small molecule derived from ML264, a KLF5 inhibitor that elicits cytotoxic effects in colon cancer cell lines. YD277 significantly induced G1 cell cycle arrest and apoptosis in MDA-MB-231 and MDA-MB-468 TNBC cells, independent of KLF5 inhibitio
  • Inquiry Price
Size
QTY